By Mary Johnson, editor Your Part D drug plan would never tell you this, but the alarming fact is that there is no limit to what you might spend out-of-pocket for your prescriptions drugs in any given year. While t ...
Category: Medicare Part D Articles
Don’t Let The High Cost Of Prescription Drugs Cost You Your Health
(Washington, DC) – For older Americans, the high cost of prescription drugs is a leading deterrent to filling prescriptions or taking required medications as directed, warns The Senior Citizens League. “People with Medi ...
Benefit Bulletin: November 2017
Despite Support, No Bill Moving On Medicare Drug Price Negotiations Ninety percent of the people participating in TSCL’s 2017 Senior Survey support giving Medicare the power to negotiate lower drug prices. But so far ...
Benefit Bulletin: August 2017
Drug Rebates Often Not Going To Patients A behind-the-scene rebate game between drug makers, health insurers and their pharmacy benefit managers is costing you and the Medicare program in higher drug costs. A researc ...
Retiree Testifies Costs For One Drug Went From $700 To $10,000
Sudden price spikes in older drugs are putting patients at risk of going without vital medicine. A new report by the U.S. Senate Special Committee on Aging uncovered an insidious business model that’s leading to monopol ...
Benefit Bulletin: February/March 2017
What a New Congress Means For Medicare TSCL is closely following proposals that would overhaul Medicare as a part of the plans to repeal the 2010 Affordable Care Act. House Speaker Paul Ryan (WI) has put forward a pl ...
What’s A Medicare “Buy-In”?
In the debate over rising healthcare costs, attention has focused on people age 50 to 64 who are among those with the highest premiums, deductibles, and out-of-pocket costs. Some policy experts say that removing these ...
High Drug Prices A Major Issue For The Next Congress
The EpiPen, the latest example in extreme drug price hikes, has not only led to Congressional hearings and outrage over price gouging, but is raising new questions as to why so many older adults are getting prescriptions ...
Medicare Proposes Tying Drug Costs to Effectiveness
The Centers for Medicare and Medicaid Services (CMS) recently announced plans to test new ways to rein in costs of some of the nation’s most expensive drugs, like cancer and rheumatoid arthritis treatments, that are admi ...
Drug Pricing Abuse Comes Under New Scrutiny
The drug industry’s secretive pricing practices are coming under increasing scrutiny in Congress. According to a recent poll, the public thinks making sure that high-cost drugs for chronic conditions are affordable to th ...
Close